Continuous Dosing vs Interrupted Therapy With Ixekizumab for Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Continuous Dosing Versus Interrupted Therapy With Ixekizumab: An Integrated Analysis of Two Phase 3 Trials in Psoriasis
J Eur Acad Dermatol Venereol 2017 Feb 11;[EPub Ahead of Print], A Blauvelt, KA Papp, H Sofen, M Augustin, G Yosipovitch, N Katoh, U Mrowietz, M Ohtsuki, Y Poulin, D Shrom, R Burge, K See, L Mallbris, KB GordonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.